EP 4304598 A1 20240117 - THERAPEUTIC COMPOSITION FOR ERECTILE DYSFUNCTION TREATMENT
Title (en)
THERAPEUTIC COMPOSITION FOR ERECTILE DYSFUNCTION TREATMENT
Title (de)
THERAPEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON EREKTILER DYSFUNKTION
Title (fr)
COMPOSITION THÉRAPEUTIQUE POUR LE TRAITEMENT DE LA DYSFONCTION ÉRECTILE
Publication
Application
Priority
- GE AU2020015494 U 20201119
- IB 2021060706 W 20211118
Abstract (en)
[origin: WO2022107042A1] Composition contains sydenafil citrate and tadalafil as active ingredients, and dicalcium phosphate dihydrate, microcrystalline cellulose, starch sodium glycidolate, colloidal silicon dioxide and magnesium stearate – as pharmaceutically acceptable additives.
IPC 8 full level
A61K 31/4985 (2006.01); A61K 9/48 (2006.01); A61K 31/519 (2006.01); A61P 15/00 (2006.01)
CPC (source: EP)
A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 31/4985 (2013.01); A61K 31/519 (2013.01); A61K 31/57 (2013.01); A61P 15/00 (2017.12); A61P 15/10 (2017.12)
C-Set (source: EP)
Citation (search report)
See references of WO 2022107042A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022107042 A1 20220527; EP 4304598 A1 20240117; GE U20212096 Y 20210927
DOCDB simple family (application)
IB 2021060706 W 20211118; EP 21894156 A 20211118; GE AU2020015494 U 20201119